
Dr. Marty Makary
@DrMakaryFDA • 58,225 subscribers
Official account of the 27th Commissioner of the @US_FDA Catch up with FDA Direct: https://t.co/QJ6g8bH7wc
Shorts
Videos

TWO DAYS after receiving the application, FDA greenlit the new pancreatic cancer drug daraxonrasib for expanded access. This drug has also been granted a national priority voucher, which means a full application could be reviewed in a matter of weeks instead of 10-12 months.
Dr. Marty Makary416,245 Aufrufe • vor 2 Monaten

For far too long, we’ve watched an expanding autism epidemic with no good answers.
Dr. Marty Makary622,874 Aufrufe • vor 10 Monaten

FDA is moving with unprecedented agility. Today we approved a multiple myeloma drug just 55 days after the application was filed. And last week’s approval (a major leap forward) was approved in 44 days. If a trial result shows immediate promise for many Americans, why wait?
Dr. Marty Makary272,146 Aufrufe • vor 4 Monaten

We’re cutting red tape on wearables for general wellness.
Dr. Marty Makary305,988 Aufrufe • vor 6 Monaten

FDA just completed the largest-ever testing of infant formula testing (covering 300 products), part of our broader approach to deliver for American families. 🍼 Rigorous testing and oversight 🍼 Re-evaluating nutrient requirements to allow for more innovative products 🍼 Building more secure supply chain
Dr. Marty Makary130,217 Aufrufe • vor 2 Monaten

Today we’re taking long-overdue action to rein in pharmaceutical ads. For too long, misleading ads have distorted the doctor-patient relationship and driven costly, inappropriate care. Our actions will encompass online pharmacies promoting drugs with no mention of side effects, and paid social media influencers advertising drugs.
Dr. Marty Makary436,401 Aufrufe • vor 10 Monaten

Today, the FDA is taking action to remove concentrated ingestible fluoride prescription drug products for children from the market. A growing body of research is demonstrating how ingested fluoride can alter the gut microbiome. This is especially concerning with young children where the microbiome is in a critical state of development. When it comes to children, this FDA will always err on the side of safety.
Dr. Marty Makary523,020 Aufrufe • vor 1 Jahr
